Medibank Private Ltd, Westpac Banking Corp and Telstra Corporation Ltd: Should you buy?

Juicy fully franked dividend yields are on offer, but are Medibank Private Ltd (ASX:MPL), Westpac Banking Corp (ASX:WBC) and Telstra Corporation Ltd (ASX:TLS) in the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

By all accounts 2015 is set to be another year characterised by low yields…

Well, that's unless you're in the share market.

You see whilst much of the world grapples with easy monetary policy (i.e. low interest rates), the share market receives a welcome boost from investors searching for higher returns.

Indeed a relatively flat performance from the local S&P/ASX 200 (ASX: XJO) (INDEX: ^AXJO) this year, means there could still be opportunities for investors to grab a hold of some reasonably priced dividend stocks.

Telstra Corporation Ltd (ASX: TLS), Westpac Banking Corp (ASX: WBC) and, more recently, Medibank Private Ltd (ASX: MPL) are examples of companies which spring to mind when dividends are brought up.

Here's what you need to know about them…

Telstra is forecast to pay a dividend of 30 cents per share in 2015, placing the stock on a yield of exactly 5%, fully franked. Next to the 3% or 4% on offer from term deposits that may appear great. However at $6.00, its shares don't come cheap and are probably best left on investors' watchlists until we're afforded a more compelling buying opportunity.

Westpac too is offering a big dividend yield, forecast at 5.8% fully franked. By itself the yield represents a grossed-up return of 8.3%, which is great. However with shares above fair value and little growth in the pipeline, patiently waiting on the sidelines for a lower price is likely to be a prudent way forward.

Medibank, the government's most recent major privatisation, has performed strongly since listing on the ASX last month. Indeed retail shareholders who bought into the IPO are today sitting on gains of 15%. Looking further ahead however, unless Medibank can meet its cost and investing performance forecasts, its share price (currently trading at 21 times forecast FY16 earnings per share) could come under selling pressure. With an interim dividend of just 4.9 cents to be declared in 2015, currently the downside is likely outweighing the upside potential.

A better dividend stock idea than Medibank in 2015 – Yours FREE!

Motley Fool Contributor Owen Raszkiewicz owns shares of Medibank Private. You can follow Owen on Twitter @ASXinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »